Tango Therapeutics, Inc. (TNGX)
22.90
+0.71
(+3.20%)
USD |
NASDAQ |
Oct 27, 16:00
23.00
+0.10
(+0.41%)
After-Hours: 19:49
Tango Therapeutics Market Cap : 3.857B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 3.737B |
| October 23, 2026 | 3.930B |
| October 22, 2026 | 4.703B |
| October 21, 2026 | 4.543B |
| October 20, 2026 | 4.252B |
| October 19, 2026 | 3.962B |
| October 16, 2026 | 3.711B |
| October 15, 2026 | 3.822B |
| October 14, 2026 | 3.736B |
| October 13, 2026 | 3.741B |
| October 12, 2026 | 4.070B |
| October 09, 2026 | 4.009B |
| October 08, 2026 | 3.800B |
| October 07, 2026 | 3.676B |
| October 06, 2026 | 3.688B |
| October 05, 2026 | 3.886B |
| October 02, 2026 | 3.913B |
| October 01, 2026 | 4.117B |
| September 30, 2026 | 4.201B |
| September 29, 2026 | 4.112B |
| September 28, 2026 | 4.092B |
| September 25, 2026 | 4.196B |
| September 24, 2026 | 4.147B |
| September 23, 2026 | 4.117B |
| September 22, 2026 | 4.299B |
| Date | Value |
|---|---|
| September 21, 2026 | 3.760B |
| September 18, 2026 | 3.662B |
| September 17, 2026 | 3.955B |
| September 16, 2026 | 3.932B |
| September 15, 2026 | 4.023B |
| September 14, 2026 | 4.132B |
| September 11, 2026 | 4.004B |
| September 10, 2026 | 3.935B |
| September 09, 2026 | 4.041B |
| September 08, 2026 | 3.822B |
| September 04, 2026 | 3.792B |
| September 03, 2026 | 3.832B |
| September 02, 2026 | 3.758B |
| September 01, 2026 | 3.763B |
| August 31, 2026 | 3.846B |
| August 28, 2026 | 3.930B |
| August 27, 2026 | 4.257B |
| August 26, 2026 | 4.289B |
| August 25, 2026 | 4.171B |
| August 24, 2026 | 4.127B |
| August 21, 2026 | 4.021B |
| August 20, 2026 | 3.959B |
| August 19, 2026 | 4.243B |
| August 18, 2026 | 4.284B |
| August 17, 2026 | 4.258B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.572B |
| NovelStem International Corp. | 0.3256M |
| Brainstorm Cell Therapeutics, Inc. | 8.521M |
| Summit Therapeutics, Inc. | 12.16B |
| Kezar Life Sciences, Inc. | 53.76M |
Market Cap Related Metrics
| PS Ratio | 57.04 |
| Price to Book Value | 3.764 |
| Price | 22.90 |
| Earnings Yield | -3.66% |